Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 Dissection
This study is currently recruiting participants.
Verified February 2016 by Shen Lin, Peking University
First Posted: February 16, 2012
Last Update Posted: February 8, 2016
Taiho Pharmaceutical Co., Ltd.
Information provided by (Responsible Party):
Shen Lin, Peking University
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||September 2019|
|Estimated Primary Completion Date:||September 2017 (Final data collection date for primary outcome measure)|